Home > Financial Ratios > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
EV/Net Sales

    Back to All Ratios
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year EV/Net Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Net Sales(x) 3.302.231.411.201.52

What is the latest EV/Net Sales ratio of GLENMARK PHARMACEUTICALS ?

The latest EV/Net Sales ratio of GLENMARK PHARMACEUTICALS is 3.30 based on Mar2025 Consolidated results.
Year EV/Net Sales
Mar20253.30
Mar20242.23
Mar20231.41
Mar20221.20
Mar20211.52

How is EV/Net Sales of GLENMARK PHARMACEUTICALS Trending?

Years EV/Net Sales % Change
Mar2025 3.3
47.98
Mar2024 2.23
58.16
Mar2023 1.41
17.50
Mar2022 1.2
-21.05
Mar2021 1.52 -

Other Financial Ratios of GLENMARK PHARMACEUTICALS


Compare EV/Net Sales ratio of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹59,549.8 Cr -0.8% 7.9% 55.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹427,777.0 Cr -0.1% 4.7% 6.2% Stock Analytics
DIVIS LABORATORIES ₹168,931.0 Cr -1.7% 2.5% 12.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹147,330.0 Cr -1.1% 7.6% 45.4% Stock Analytics
DR REDDYS LABORATORIES ₹109,593.0 Cr -0.4% 6.3% 14.7% Stock Analytics
CIPLA ₹107,112.0 Cr -2.3% 0.3% -8.9% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-0.8%

7.9%

55.3%

SENSEX

-2.8%

-2%

7.3%


You may also like the below Video Courses